ArTS Archivio della ricerca di Trieste

FANIN, RENATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.516
AS - Asia 2.563
EU - Europa 1.455
SA - Sud America 427
Continente sconosciuto - Info sul continente non disponibili 314
AF - Africa 159
OC - Oceania 1
Totale 10.435
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.416
SG - Singapore 1.126
SE - Svezia 431
CN - Cina 383
HK - Hong Kong 341
BR - Brasile 320
VN - Vietnam 301
IT - Italia 187
FR - Francia 145
RU - Federazione Russa 120
KR - Corea 119
PL - Polonia 113
DE - Germania 96
MA - Marocco 96
BG - Bulgaria 85
IE - Irlanda 83
GB - Regno Unito 67
BD - Bangladesh 66
IN - India 62
CA - Canada 52
AR - Argentina 36
MX - Messico 23
UA - Ucraina 22
ID - Indonesia 21
TR - Turchia 20
ZA - Sudafrica 20
FI - Finlandia 19
IQ - Iraq 19
EC - Ecuador 17
ES - Italia 17
BE - Belgio 16
CO - Colombia 15
NL - Olanda 15
JP - Giappone 14
PK - Pakistan 13
CL - Cile 11
SN - Senegal 10
JO - Giordania 9
AE - Emirati Arabi Uniti 8
AT - Austria 7
CH - Svizzera 7
DZ - Algeria 7
EG - Egitto 7
JM - Giamaica 7
KE - Kenya 7
NP - Nepal 7
PY - Paraguay 7
BO - Bolivia 6
SA - Arabia Saudita 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
LT - Lituania 5
PE - Perù 5
UZ - Uzbekistan 5
VE - Venezuela 5
IL - Israele 4
PH - Filippine 4
UY - Uruguay 4
HU - Ungheria 3
MN - Mongolia 3
MY - Malesia 3
OM - Oman 3
RO - Romania 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BS - Bahamas 1
BT - Bhutan 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
Totale 10.119
Salva come PNG Salva come JPEG
Città #
Singapore 812
Ashburn 747
Fairfield 615
Hong Kong 338
San Jose 334
Woodbridge 277
Chandler 257
Wilmington 242
Houston 241
Seattle 239
Cambridge 207
Princeton 168
Boardman 153
Beijing 147
Ann Arbor 137
Seoul 115
Santa Clara 110
Ho Chi Minh City 107
Chicago 97
Lauterbourg 89
Casablanca 88
Jacksonville 86
Sofia 84
Dublin 83
Zgierz 81
Columbus 80
Council Bluffs 68
Los Angeles 68
The Dalles 59
Hanoi 57
Milan 54
Moscow 51
Dallas 47
San Diego 45
New York 41
Frankfurt am Main 33
São Paulo 33
Hefei 31
Warsaw 28
Düsseldorf 24
Orem 21
Montreal 19
Buffalo 18
Da Nang 17
Trieste 16
Brooklyn 15
Brussels 15
Miano 15
Helsinki 14
Chennai 13
Johannesburg 13
Norwalk 13
Phoenix 13
London 12
Tokyo 12
Toronto 12
Atlanta 11
Memphis 11
Philadelphia 11
Washington 11
Dakar 10
Munich 10
Rio de Janeiro 10
Bremen 9
Haiphong 9
Mexico City 9
Poplar 9
Redondo Beach 9
Amman 8
Campinas 8
Can Tho 8
Portsmouth 8
Santiago 8
Andover 7
Boston 7
Charlotte 7
Monmouth Junction 7
Raleigh 7
Stockholm 7
Tianjin 7
Augusta 6
Baghdad 6
Bern 6
Biên Hòa 6
Curitiba 6
Fremont 6
Lahore 6
Nanjing 6
Pune 6
Shanghai 6
Ankara 5
Belo Horizonte 5
Brasília 5
Cairo 5
Guangzhou 5
Guayaquil 5
Jeddah 5
Kocaeli 5
Manchester 5
Mumbai 5
Totale 7.129
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 190
Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases 187
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma 181
Low-dose rituximab in adult patients with primary immune thrombocytopenia 180
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation 179
Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice 176
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results 174
Rituximab for the treatment of type II mixed cryoglobulinemia 168
Efficacy of selective B cell Blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells 168
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia 167
Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia 167
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response 166
Bendamustine salvage therapy for T cell neoplasms 165
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 163
Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion 161
B-cell compartment as the selective target for the treatment of immune thrombocytopenias 161
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia 161
CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma 159
Management of immune thrombocytopenia in elderly patients 158
Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant 155
Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patients 155
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab 154
The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma 154
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia 152
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters 151
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia 146
Surgical staging in Hodgkin's disease: the role of laparoscopic splenectomy 142
T-cell chimerism and clinical outcome after reduced-intensity conditioning allogeneic stem cell transplantation 141
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma 141
A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of aurtologoaus stem cell transplantation in first remission on autcome 136
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation 132
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura 131
Brentuximab vedotin in combination with extended field radiotherapy as salvage treatment for primary refractory Hodgkin lymphoma 129
High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome 129
Rituximab in a case of cold agglutinin disease 128
CD38, BCL-2, PD-1 and PD-1L expression in nodal peripheral T-cell lymphoma (PTCL): Possible biomarkers for novel targeted therapies? 128
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 127
Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin’s lymphomas 127
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine 127
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia 125
Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording 123
Clinical features and outcome of multiple myeloma arising from the transformation of a monoclonal gammapathy of undetermined significance 123
Granulocyte colony-stimulating factor (G-CSF) allows the delivery of effective doses of CHOP and CVP regimens in non-Hodgkin lymphomas 120
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: A phase II clinical trial of the fondazione italiana linfomi 120
Treatment of refractory chronic GVHD with rituximab: a GITMO study 119
Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma 118
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: Results of a retrospective, observational GIMEMA study 115
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? 111
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 109
Paraneoplastic cerebellar degeneration associated with anti-neuronal anti-Tr antibodies in a patient with Hodgkin's disease 108
Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia 108
The role of granulocyte colony-stimulating factor (filgrastim) in maintaining dose intensity during conventional-dose chemotherapy with ABVD in Hodgkin's disease 108
Prevalence of Hepatitis C Virus infection in patients with lymphoproliferative disorder 108
Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment 107
Computed tomography, magnetic resonance and gallium 67 scintigraphy for the imaging of residual lymphoma 106
Risk of C virus infection in Waldenstrom’s syndromes and monoclonal gammopathies 106
Meningeal and cerebral involvement in multiple myeloma patients 105
High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience 105
Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients 103
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 103
The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: results of 40 cases treated in a single center 102
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults 98
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma 94
Hepatitis C virus infection (and additional neoplasms) among marginal zone lymphomas 94
Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous bone marrow transplantation 93
The role of Rituximab in the therapy of mixed cryoglobulinemia 92
Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome 92
The F-MACHOP regimen in the treatment of aggressive non-Hodgkin’s lymphomas: a single centre experience in 72 patients 92
Hepatitis C virus and lymphoproliferative disorders 90
Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas 88
Myasthenia gravis after allogeneic bone marrow transplantation: a case report 87
No evidence for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy” 85
Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha 85
Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome 83
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab 81
Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome 81
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies 81
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery 78
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers 74
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation 74
Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine 73
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study 72
Myasthenia gravis after allogeneic bone marrow transplantation. A case report and a review of the literature 60
Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous transplantation 58
Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma 52
High JAK2V617F allele burden in low-risk PV: an additional recommendation to start “early” cytoreduction? Results from a multicentric study 10
Totale 10.435
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.301
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022814 0 0 2 131 4 23 49 32 113 73 38 349
2022/2023971 117 127 102 60 101 191 1 104 114 17 32 5
2023/2024689 28 29 69 15 33 94 122 181 30 10 44 34
2024/20251.629 3 242 273 98 111 134 76 70 112 154 140 216
2025/20263.596 373 122 191 444 319 276 558 110 361 585 135 122
2026/2027380 91 138 151 0 0 0 0 0 0 0 0 0
Totale 10.435